Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Boehringer Ingelheim
Mallinckrodt
AstraZeneca
McKinsey

Last Updated: January 16, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Epicatechin


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Epicatechin?

Epicatechin is an investigational drug.

There have been 15 clinical trials for Epicatechin. The most recent clinical trial was a Phase 2 trial, which was initiated on June 20th 2021.

The most common disease conditions in clinical trials are Muscular Dystrophy, Duchenne, Muscular Dystrophies, and Prediabetic State. The leading clinical trial sponsors are Cardero Therapeutics, Inc., Craig McDonald, MD, and National Center for Complementary and Integrative Health (NCCIH).

There are two hundred and twenty-three US patents protecting this investigational drug and three international patents.

Recent Clinical Trials for Epicatechin
TitleSponsorPhase
Evaluation of The Effect of Rutin and Vitamin C on the Oxidative Stress in Hemodialysis PatientsAin Shams UniversityPhase 3
Safety and Biomarker Response to (+)-Epicatechin in Becker Muscular DystrophyEpirium Bio Inc.Phase 1
Cocoa to Improve Walking Performance in Peripheral Artery DiseaseNational Institute on Aging (NIA)N/A

See all Epicatechin clinical trials

Clinical Trial Summary for Epicatechin

Top disease conditions for Epicatechin
Top clinical trial sponsors for Epicatechin

See all Epicatechin clinical trials

US Patents for Epicatechin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Epicatechin ⤷  Sign up for a Free Trial Method of identifying a biologically-active composition from a biofilm QUORUM INNOVATIONS, LLC (Sarasota, FL) ⤷  Sign up for a Free Trial
Epicatechin ⤷  Sign up for a Free Trial Bioactive compositions from Theacea plants and processes for their production and use ISP INVESTMENTS LLC (Wilmington, DE) ⤷  Sign up for a Free Trial
Epicatechin ⤷  Sign up for a Free Trial Polypeptides having beta-xylosidase activity and polynucleotides encoding same Novozymes, Inc. (Davis, CA) ⤷  Sign up for a Free Trial
Epicatechin ⤷  Sign up for a Free Trial Selectivity of the production of vanilloids in a recombinant unicellular host RHODIA OPERATIONS (Paris, FR) ⤷  Sign up for a Free Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Epicatechin

Drugname Country Document Number Estimated Expiration Related US Patent
Epicatechin China CN103687604 2031-03-01 ⤷  Sign up for a Free Trial
Epicatechin China CN111518866 2031-03-01 ⤷  Sign up for a Free Trial
Epicatechin European Patent Office EP2680866 2031-03-01 ⤷  Sign up for a Free Trial
Epicatechin Japan JP2014506923 2031-03-01 ⤷  Sign up for a Free Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Boehringer Ingelheim
Mallinckrodt
AstraZeneca
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.